TxA2-mediated myocardial ischemia as a consequence of an acute lung inflammatory reaction in the rabbit

V Evangelista1, G Dell'Elba, A Celardo

  • 1G. Bizzozero Laboratory of Blood and Vascular Cell Interactions, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy. evangeli@negrisud.it

Insights

Respiratory infections transiently increase heart attack risk. Lung inflammation activates immune cells and platelets, releasing mediators like thromboxane A2 (TxA2), causing myocardial ischemia, especially in hypercholesterolemic rabbits.

Area of Science:

  • Cardiovascular Research
  • Inflammation and Immunology
  • Pulmonary Medicine

Background:

  • Acute respiratory tract infections are linked to a temporary rise in acute myocardial infarction (heart attack) risk.
  • The precise biological mechanisms underlying this association remain unclear.
  • Vasoactive mediators released from lung inflammatory cells may enter coronary circulation, triggering myocardial ischemia.

Purpose of the Study:

  • To investigate the hypothesis that inflammatory mediators from the lungs can induce acute myocardial ischemia.
  • To elucidate the role of specific inflammatory cells and mediators in this process.
  • To examine the influence of hypercholesterolemia on this phenomenon.

Main Methods:

  • An experimental rabbit model was utilized.
  • The bacterial peptide N-formyl-Met-Leu-Phe (fMLP) was injected intravenously to induce lung inflammation and mediator release.
  • Electrocardiographic (ECG) changes, hemodynamic parameters, and inflammatory cell/platelet recruitment were monitored.
  • The effects of aspirin and ridogrel (a thromboxane inhibitor) were assessed.

Main Results:

  • fMLP injection caused rapid polymorphonuclear leukocyte (PMN) and platelet recruitment in lung microcirculation.
  • Significant increases in leukotrienes and thromboxane A2 (TxA2) were observed in aortic blood.
  • fMLP induced transient ischemic ECG changes, bradycardia, and hypotension.
  • Aspirin prevented ECG changes and hemodynamic alterations but not cell recruitment.
  • Ridogrel prevented ECG changes and bradycardia, but worsened hypotension and only partially inhibited platelet sequestration.
  • In hypercholesterolemic rabbits, ECG alterations were more prolonged.

Conclusions:

  • Acute activation of PMN and platelets in the lungs can precipitate transient myocardial ischemia.
  • Thromboxane A2 (TxA2) is identified as a primary mediator of this ischemic event.
  • Hypercholesterolemia exacerbates the duration of myocardial ischemia.
  • A balance between TxA2 and prostacyclin (PGI2) appears crucial for platelet activation and recruitment in this model.